IL17A and myeloid sarcoma: The IL-17 family of cytokines and Th17 cells have been shown to play important roles in the pathogenesis of MS, and IL-17A and IL-17F have been shown to increase the pro-inflammatory response in the endothelial and glial cells in the central nervous system [13].